Laser cyclophotocoagulation is a laser treatment used to decrease pressure inside the eye (intraocular pressure).
Pneumatic retinopexy (PR) was introduced by Hilton and Grizzard in 1986 as an outpatient procedure to repair rhegmatogenous retinal detachments.
Pars plana vitrectomy (PPV) is a microsurgical procedure used by retina surgeons to perform a variety of operations. The first step in this procedure is to remove the “vitreous gel” that fills the back of the eye (hence “vitrectomy”).
Bardet–Biedl syndrome (BBS) is a ciliopathic human genetic disorder that produces many effects and affects many body systems. It is characterized by rod/cone dystrophy, polydactyly, central obesity, hypogonadism, and kidney dysfunction in some cases.
Three-dimensional (3D) surgical visualization systems allow ophthalmic surgeons to free their eyes from standard surgical microscope eyepieces and replace them with high-resolution dual-camera systems that will transmit images on a panel in front of them.
It is characterized by decreased or absent corneal sensation, leading to epithelial breakdown, impairment of healing, and ultimately to the development of corneal ulceration, melting and perforation.
Major advances in diagnostic technologies are offering unprecedented insight into the condition of the retina and beyond ocular disease.
Elevated intraocular pressure (IOP) is the most significant risk factor for developing glaucoma and the only known risk factor that is currently treatable. In patients who already have glaucoma, reducing IOP slows the progression of the disease.
Diabetic eye disease is a group of eye problems that can affect people with diabetes. These conditions include diabetic retinopathy, diabetic macular edema, cataracts, and glaucoma.
Optical coherence tomography angiography (OCTA) is a non-invasive imaging technique that provides three-dimensional visualization of perfused vasculature of the retina and choroid.